2012
DOI: 10.1183/09031936.00181812
|View full text |Cite
|
Sign up to set email alerts
|

The ambition of theEuropean Respiratory Journal

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
7
0

Year Published

2013
2013
2014
2014

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 21 publications
0
7
0
Order By: Relevance
“…Although this high acceptance threshold means that sometimes we have to reject high-quality science, it allows us to distill out the very best submissions. We have also tried to help authors to publish by fulfilling two more of the ambitions set out in 2013 [1]: increasing the number of research letters published (as part of the new Agora section) and offering some authors the opportunity to resubmit to the European Respiratory Review. On a larger scale, the European Respiratory Society (ERS) is responding to the great demand from authors for an additional publishing outlet, and is in the process of launching ERJ Open Research, a new addition to the ERS publications family.…”
mentioning
confidence: 99%
“…Although this high acceptance threshold means that sometimes we have to reject high-quality science, it allows us to distill out the very best submissions. We have also tried to help authors to publish by fulfilling two more of the ambitions set out in 2013 [1]: increasing the number of research letters published (as part of the new Agora section) and offering some authors the opportunity to resubmit to the European Respiratory Review. On a larger scale, the European Respiratory Society (ERS) is responding to the great demand from authors for an additional publishing outlet, and is in the process of launching ERJ Open Research, a new addition to the ERS publications family.…”
mentioning
confidence: 99%
“…The European Respiratory Journal (ERJ), the flagship publication of the European Respiratory Society (ERS), is launching a new section on novel concepts in physiology, immunology, biology and translational medicine [1,2]. Within this Back to Basics section, we aim to present cutting edge knowledge and emerging ideas on topics relevant to respiratory medicine.…”
Section: Albert Einsteinmentioning
confidence: 99%
“…
@ERSpublicationsThe #ERJ launches a new Back to Basics section discussing novel concepts in basic science and translational medicine http://ow.ly/y8SL5We can't solve problems by using the same kind of thinking we used when we created them.
Albert EinsteinThe European Respiratory Journal (ERJ), the flagship publication of the European Respiratory Society (ERS), is launching a new section on novel concepts in physiology, immunology, biology and translational medicine [1,2]. Within this Back to Basics section, we aim to present cutting edge knowledge and emerging ideas on topics relevant to respiratory medicine.
…”
mentioning
confidence: 99%
“…The transfer of manuscript submissions from one journal to the other has already been made easier and faster, and the ERR editorial board will work closely with the ERJ Chief Editor Professor Marc Humbert and Professor Anh-Tuan Dinh-Xuan, now ERJ deputy editor, who are also members of the ERR editorial board [3,14,20]. Correspondence articles referring to previously published ERR articles and Letters to the editor, corresponding to very short reports or to highlyselected case studies that harbour educational excellence or particular relevance for diagnosis or management, now have distinct formats, in line with the ERJ.…”
Section: Expanding and Targeting New Challengesmentioning
confidence: 99%
“…Part of the fleet of ERS publications [1,14], the ERR provides quarterly updates on medicine, science and surgery for all respiratory medicine professionals, and will continue to be primarily focused on clinical respiratory medicine. In recent years, the ERR has published a number of outstanding review articles on chronic obstructive pulmonary disease, asthma, pulmonary hypertension, venous thromboembolic disease, interstitial lung disease, tuberculosis and cancer.…”
mentioning
confidence: 99%